Core Viewpoint - The Panamanian government has accused Panama Ports Company (PPC), a subsidiary of CK Hutchison Holdings, of violations during its nearly 30-year operation of two major ports on the Panama Canal, leading to legal disputes and international arbitration claims for compensation of at least $2 billion [1][2]. Group 1: Legal and Regulatory Developments - The Supreme Court of Panama declared the contract authorizing PPC to operate the ports unconstitutional, resulting in the government's takeover of Balboa and Cristobal ports in February [1]. - PPC has initiated international arbitration under the rules of the International Chamber of Commerce, claiming damages of at least $2 billion [1]. - The Panamanian government has requested a partial delay in responding to the arbitration, citing the need for time to prepare and the absence of legal representation [1]. Group 2: Company Responses and Future Plans - CK Hutchison's joint managing director, Li Fai-lam, stated that the company is actively seeking legal remedies through domestic and international channels to address the situation regarding the port contracts [2]. - The company is in discussions with consortium members and major strategic investors from mainland China regarding the potential sale of global port assets [2]. - Li confirmed that the company will provide updates on the arbitration progress at an appropriate time and continues negotiations with the original buyer consortium [2].

Core Viewpoint - Goldman Sachs maintains a "neutral" relative rating on Cheung Kong Infrastructure Holdings (01038), adjusting profit forecasts for 2026 and 2027 based on recent business trends and realized gains from the sale of UK rail assets [2] Group 1: Financial Performance - Cheung Kong Infrastructure's profit attributable to shareholders for 2025 is projected at HKD 8.3 billion, with core earnings (excluding one-off items) expected to grow by 6% year-on-year to HKD 8.5 billion, aligning with Goldman Sachs' expectations [2] - Contributions from Europe and New Zealand significantly boosted performance, with Europe showing a year-on-year increase of 58% to HKD 1 billion, and New Zealand up 8% to HKD 200 million [2] Group 2: Strategic Moves - The proposed sale of UKPN to Engie for GBP 10.5 billion is expected to allow the company to realize investments, confirming an accounting gain of HKD 14.5 billion and cash proceeds of HKD 45 billion [3] - Following the transaction, Cheung Kong Infrastructure anticipates holding over HKD 30 billion in net cash, assuming the cash proceeds are received [3] Group 3: Market Performance and Valuation - The stock price of Cheung Kong Infrastructure has risen 13% year-to-date, potentially benefiting from favorable currency movements and market expectations of profit recovery post-regulatory reset [3] - The stock appears reasonably valued with a projected price-to-earnings ratio of 15 times for 2026 and a dividend yield of 4.1%, compared to a 4.2% yield on 10-year U.S. Treasury bonds [3]

Core Viewpoint - Tengsheng Bo Pharmaceutical-B (02137) reported a significant increase in revenue for the fiscal year ending December 31, 2025, amounting to RMB 18.605 million, compared to zero revenue in the same period last year. The company also narrowed its net loss to RMB 222.3 million, a 56.19% improvement year-on-year, with a loss per share of RMB 0.31 [2]. Financial Performance - The company's revenue increased due to payments received under a licensing and technology transfer agreement with Health Yuan Group (600380) [2]. - The net loss for the year was RMB 222.3 million, which represents a 56.19% reduction compared to the previous year [2]. - Earnings per share were reported at a loss of RMB 0.31 [2].

Core Viewpoint - The company reported a total revenue of HKD 507.297 billion for the year ending December 31, 2025, representing a year-on-year increase of 6% [2] - The company experienced a decrease in net profit after tax of 19%, amounting to HKD 19.233 billion, and a 31% decline in profit attributable to ordinary shareholders, totaling HKD 11.841 billion [2] - The company plans to distribute a final dividend of HKD 1.602 per share [2] Financial Performance - The reported EBITDA for the year was HKD 129.105 billion, reflecting a 3% year-on-year growth [2] - Excluding one-time losses and based on pre-IFRS 16 standards, the company recorded a basic net profit of HKD 22.258 billion, which is a 7% increase compared to 2024 [3] - Basic EBITDA and EBIT, calculated in reported currency, increased by 9% year-on-year, driven by significant growth in the port sector and strong performance from CK Hutchison Group Telecom [3] Major Transactions - The company completed a merger of its UK telecommunications business with Vodafone UK, which resulted in a one-time non-cash loss of HKD 10.922 billion [2] - In 2024, the company recognized a one-time non-cash impairment and other provisions related to its Vietnam telecommunications business amounting to HKD 3.74 billion [2] - The company announced the sale of its 100% stake in UK Power Networks to Engie S.A., expected to generate significant cash flow and net profit for the company in 2026 [2]

长和 分时图 日K线 周K线 月K线 60.30 0.35 0.58% 3.75% 2.50% 1.25% 0.00% 1.25% 2.50% 3.75% 57.70 58.45 59.20 59.95 60.70 61.45 62.20 09:30 10:30 12:00/13:00 14:00 16:10 0 689万 1379万 2068万 长和(00001)发布公告，该公司将于2026年6月11日派发末期股息每股1.602港元。 ...

长和 分时图 日K线 周K线 月K线 60.30 0.35 0.58% 3.75% 2.50% 1.25% 0.00% 1.25% 2.50% 3.75% 57.70 58.45 59.20 59.95 60.70 61.45 62.20 09:30 10:30 12:00/13:00 14:00 16:10 0 689万 1379万 2068万 长和(00001)发布公告，周近智先生已决定于2026年5月21日(或于将刊发之会议通告内详述的其他日期) 举行之本公司2026年股东周年大会结束后退任本公司非执行董事，以便投放更多时间于其他商业及个人 承诺上;及李业广先生将于2026年股东周年大会上轮值告退，而李先生已通知本公司彼将不会于2026年 股东周年大会上寻求膺选连任，并将于2026年股东周年大会结束后退任本公司非执行董事，以便投放更 多时间于其他商业及个人承诺上。 ...

Group 1 - Southbound funds increased their holdings in Alibaba Health (00241.HK) by 2.146 million shares on March 20 [1] - Over the past 5 trading days, there were 4 days of net increases in holdings by southbound funds, totaling 15.4508 million shares [1] - In the last 20 trading days, there were 12 days of net increases, amounting to 34.0052 million shares [1] Group 2 - As of now, southbound funds hold 2.01 billion shares of Alibaba Health, representing 12.41% of the company's total issued ordinary shares [1] - Alibaba Health Information Technology Co., Ltd. provides industrial internet solutions for the medical and pharmaceutical industry [1] - The company is primarily engaged in the sales of pharmaceutical health products and operates e-commerce platforms for pharmaceuticals and consumer healthcare services [1]

Group 1 - The core point of the article highlights that southbound funds have increased their holdings in Melco International Development (00200.HK) by 377,000 shares on March 20, with a total net increase of 2,094,000 shares over the last five trading days [1] - Over the past 20 trading days, southbound funds have increased their holdings on 14 days, resulting in a cumulative net increase of 7,786,200 shares [1] - As of now, southbound funds hold 156 million shares of Melco International Development, accounting for 6.87% of the company's total issued ordinary shares [1] Group 2 - Melco International Development Limited primarily engages in entertainment and hotel business as an investment holding company [1] - The company operates through two segments: the entertainment and hotel segment, which includes casino operations and hotel services, and the other segment, which focuses on investment activities [1]

申洲国际集团控股有限公司是一家主要从事生产和销售针织服装产品的投资控股公司。该公司的主营业 务是从事以代工（OEM）及委托设计（ODM）相结合的方式为客户制造针织品。该公司的产品类别包 括运动类、休闲类、内衣类等其他针织品产品。该公司通过其子公司还从事贸易业务和物业管理业务。 该公司主要在国内和国外市场开展其业务。 证券之星消息，3月20日南向资金减持20.1万股申洲国际（02313.HK）。近5个交易日中，获南向资金增 持的有4天，累计净增持123.59万股。近20个交易日中，获南向资金增持的有17天，累计净增持651.11万 股。截至目前，南向资金持有申洲国际（02313.HK）1.08亿股，占公司已发行普通股的7.19%。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

Group 1 - The company China Power (02380.HK) announced a final dividend of HKD 0.168 per share to be distributed on June 30, 2026 [1]